Synthesis of SB 222618. A potential PDE IV inhibitor
JJ Conde, W Mendelson
Index: Conde, Jose J.; Mendelson, Wilford Tetrahedron Letters, 2000 , vol. 41, # 6 p. 811 - 814
Full Text: HTML
Citation Number: 19
Abstract
SB 222618 (1) has been a target of synthetic chemists at SmithKline Beecham owing to its potential PDE IV 1 inhibitor activity against inflammatory diseases such as asthma. Apart from its biological activity, this cyclohexanol provided the opportunity to explore the non-obvious construction of the quaternary C 4 of 1 whose retrosynthesis is shown below (Scheme 1). ... As depicted in Scheme 1, SB 222618 (1) could be obtained via the Sonogashira 2 coupling protocol between ...
Related Articles:
[Pouwer, Rebecca H.; Schill, Heiko; Williams, Craig M.; Bernhardt, Paul V. European Journal of Organic Chemistry, 2007 , # 28 p. 4699 - 4705]
[Allan, Graham; Carnell, Andrew J.; Hernandez, Maria Luisa Escudero; Pettman, Alan Journal of the Chemical Society, Perkin Transactions 1, 2000 , # 20 p. 3382 - 3388]
[Satoh, Tsuyoshi; Hayashi, Yasumasa; Yamakawa, Koji Bulletin of the Chemical Society of Japan, 1991 , vol. 64, # 7 p. 2153 - 2158]
[Semba, Kazuhiko; Fujihara, Tetsuaki; Terao, Jun; Tsuji, Yasushi Angewandte Chemie - International Edition, 2013 , vol. 52, # 47 p. 12400 - 12403 Angew. Chem., 2013 , vol. 125, # 47 p. 12626 - 12629,4]